Ç×VEGF ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2033³â)
Anti-VEGF Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
»óǰÄÚµå : 1518872
¸®¼­Ä¡»ç : Persistence Market Research
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 422 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,995 £Ü 7,227,000
Unprintable PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ º¹»ç, ÀμⰡ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 7,295 £Ü 10,555,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.
US $ 8,495 £Ü 12,291,000
PDF & Excel (Corporate User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Persistence Market Research´Â À̹ø¿¡ Ç×VEGF ½ÃÀå¿¡ °üÇÑ Á¾ÇÕ º¸°í¼­¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÃËÁø¿äÀΡ¤µ¿Ç⡤±âȸ¡¤°úÁ¦¸¦ Æ÷ÇÔÇÑ Áß¿ä ½ÃÀå ¿ªÇÐÀ» öÀúÈ÷ Æò°¡Çϰí, ½ÃÀå ±¸Á¶¿¡ °üÇÑ »ó¼¼ ÀλçÀÌÆ®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

Ç×VEGF ½ÃÀå - Á¶»ç ¹üÀ§ :

Ç×VEGF ¿ä¹ýÀº ³ëÈ­¼º Ȳ¹Ýº¯¼º(AMD), ´ç´¢¸Á¸·º´Áõ, ÀϺΠ¾ÏÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ÁúȯÀÇ Ä¡·á¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. À̵é Ä¡·áÁ¦´Â Ç÷°ü³»ÇǼºÀåÀÎÀÚ(VEGF)¸¦ Ç¥ÀûÀ¸·Î ÇÏ¿© Ç÷°ü½Å»ýÀ» ¾ïÁ¦Çϰí Áúº´ÀÇ ÁøÇàÀ» È¿°úÀûÀ¸·Î °ü¸®ÇÕ´Ï´Ù. Ç×VEGF ½ÃÀåÀº ÁÖ·Î º´¿ø, Ŭ¸®´Ð, ¾È°ú ¼¾ÅÍ ¹× Àü¹® Ä¡·á ½Ã¼³À» ´ë»óÀ¸·Î Çϸç, À¯¸®Ã¼°­³» ÁÖ»ç ¹× °æ±¸¿ë ¾à¹° µî ´Ù¾çÇÑ Ä¡·á ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:

¼¼°è AMD ¹× ´ç´¢¸Á¸·º´ÁõÀÇ À¯º´·ü Áõ°¡, ¾à¹°ÀÇ È¿°ú¿Í ȯÀÚ ¿¹Èĸ¦ °³¼±ÇÏ´Â ¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ ¹ßÀü, Ç×VEGF Ä¡·áÀÇ Á¶±â °³ÀÔÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÇ·áÁøµéÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ±â´ë°¨ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¾à¹°Àü´Þ ½Ã½ºÅÛÀÇ ±â¼ú Çõ½Å°ú ¿ø°ÝÀÇ·á ¼­ºñ½ºÀÇ È®´ë´Â Ä¡·á Á¢±Ù¼º°ú ȯÀÚ ¼øÀÀµµ¸¦ Çâ»ó½ÃÄÑ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀÔ´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ :

À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸Çϰí, Ç×VEGF ½ÃÀåÀº ³ôÀº Ä¡·á ºñ¿ë, ÀǾàǰ ½ÂÀÎ ¹× ½ÃÀå ÁøÀÔ°ú °ü·ÃµÈ º¹ÀâÇÑ ±ÔÁ¦, Àå±â Ä¡·á¿¡ µû¸¥ ÀáÀçÀû ºÎÀÛ¿ë°ú °ü·ÃµÈ µµÀü °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀϺΠÁö¿ª¿¡¼­´Â Ç×VEGF Ä¡·áÁ¦¿¡ ´ëÇÑ Á¦ÇÑµÈ º¸Çè Àû¿ë ¹üÀ§µµ ½ÃÀå È®´ë¿¡ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖÀ¸¸ç, ƯÈ÷ ÀÇ·áºñ ÁöÃâÀ» È¿À²ÀûÀ¸·Î °ü¸®ÇÏ·Á´Â ½ÅÈï ±¹°¡¿¡¼­´Â ´õ¿í ±×·¯ÇÕ´Ï´Ù.

½ÃÀå ±âȸ :

Ç×VEGF ½ÃÀåÀº »õ·Î¿î Á¦Çü, ¸ÂÃãÇü ÀÇ·á Á¢±Ù¹ý, ¿©·¯ Áúº´ °æ·Î¸¦ Ç¥ÀûÀ¸·Î ÇÏ´Â º´¿ë¿ä¹ý¿¡ ÃÊÁ¡À» ¸ÂÃá ¿¬±¸°³¹ßÀÌ ÁøÇà ÁßÀ̸ç, ÀÌ´Â Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. Á¦¾à»ç, ¿¬±¸±â°ü, ÀÇ·á±â°üÀÇ Àü·«Àû Á¦ÈÞ´Â ±â¼ú Çõ½ÅÀ» °¡¼ÓÈ­ÇÏ°í ¾È°ú ¹× Á¾¾çÇÐ ºÐ¾ßÀÇ ¹ÌÃæÁ· ÀÇ·á ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇØ ÇʼöÀûÀÔ´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ÁÖ¿ä ¼º°ø ¿äÀÎ

Á¦5Àå ½ÃÀå ¹è°æ

Á¦6Àå COVID-19 À§±â ºÐ¼®

Á¦7Àå ¼¼°è ½ÃÀåÀÇ ¼ö¿ä(±Ý¾× ¶Ç´Â ±Ô¸ð, 10¾ï ´Þ·¯) ºÐ¼®

Á¦8Àå ¼¼°è ½ÃÀå ºÐ¼® : ¾àÁ¦ À¯Çüº°

Á¦9Àå ¼¼°è ½ÃÀå ºÐ¼® : À¯Çüº°

Á¦10Àå ¼¼°è ½ÃÀå ºÐ¼® : Áúȯ ÀûÀÀÁõº°

Á¦11Àå ¼¼°è ½ÃÀå ºÐ¼® : À¯Åë ä³Îº°

Á¦12Àå ¼¼°è ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦13Àå ºÏ¹Ì ½ÃÀå ºÐ¼®

Á¦14Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®

Á¦15Àå À¯·´ ½ÃÀå ºÐ¼®

Á¦16Àå µ¿¾Æ½Ã¾Æ ½ÃÀå ºÐ¼®

Á¦17Àå ³²¾Æ½Ã¾Æ ½ÃÀå ºÐ¼®

Á¦18Àå ¿À¼¼¾Æ´Ï¾Æ ½ÃÀå

Á¦19Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA) ½ÃÀå ºÐ¼®

Á¦20Àå ½ÃÀå ±¸Á¶ ºÐ¼®

Á¦21Àå °æÀï ºÐ¼®

Á¦22Àå »ç¿ëµÇ´Â ÀüÁ¦ Á¶°Ç°ú µÎÀÚ¾î

Á¦23Àå Á¶»ç ¹æ¹ý

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Persistence Market Research has recently released a comprehensive report on the Anti-VEGF Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

Anti-VEGF Market - Report Scope:

Anti-VEGF therapies play a critical role in the treatment of various medical conditions, including age-related macular degeneration (AMD), diabetic retinopathy, and certain types of cancers. These therapies target vascular endothelial growth factor (VEGF) to inhibit angiogenesis and manage disease progression effectively. The Anti-VEGF Market caters primarily to hospitals, clinics, ophthalmology centers, and specialized treatment facilities, offering a range of treatment options, including intravitreal injections and oral medications.

Market Growth Drivers:

The global Anti-VEGF Market is driven by several key factors, including increasing prevalence of AMD and diabetic retinopathy globally, advancements in biotechnology enhancing drug efficacy and patient outcomes, and growing awareness among healthcare providers about the benefits of early intervention with Anti-VEGF therapies. Technological innovations in drug delivery systems and the expansion of telemedicine services further bolster market growth by improving treatment accessibility and patient compliance.

Market Restraints:

Despite promising growth prospects, the Anti-VEGF Market faces challenges related to high treatment costs, regulatory complexities governing drug approvals and market entry, and potential adverse effects associated with long-term therapy. Limited reimbursement coverage for Anti-VEGF treatments in certain regions also poses barriers to market expansion, particularly in emerging economies striving to manage healthcare expenditures effectively.

Market Opportunities:

The Anti-VEGF Market presents significant growth opportunities driven by ongoing research and development initiatives focused on novel drug formulations, personalized medicine approaches, and combination therapies targeting multiple disease pathways. Strategic collaborations between pharmaceutical companies, research institutions, and healthcare providers are essential to accelerate innovation and address unmet medical needs in ophthalmology and oncology.

Key Questions Answered in the Report:

Competitive Intelligence and Business Strategy:

Leading players in the global Anti-VEGF Market, including Roche Holding AG, Novartis AG, and Regeneron Pharmaceuticals, Inc., focus on innovation, strategic alliances, and regulatory compliance to gain a competitive edge. These companies invest significantly in clinical trials, regulatory submissions, and post-marketing surveillance to ensure product safety and efficacy. Collaborations with ophthalmologists, oncologists, and patient advocacy groups facilitate market access and promote therapeutic advancements in Anti-VEGF therapy.

Key Companies Profiled:

Key Segments of Anti-VEGF Industry Research

By Drug:

By Type:

By Disease Indication:

By Distribution Channel:

Region:

Table of Contents

1. Executive Summary

2. Market Overview

3. Key Market Trends

4. Key Success Factors

5. Market Background

6. COVID-19 Crisis Analysis

7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Drug Types

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Types

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Disease Indication

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channel

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

18. Oceania Market 2019-2023 and Forecast 2024-2033

19. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

20. Market Structure Analysis

21. Competition Analysis

22. Assumptions and Acronyms Used

23. Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â